CYP24A1 and skin basal cell carcinoma: To evaluate immunoreactivity to VDR and CYP24A1 in MCs, skin biopsies were collected from the non-lesional and lesional skin of patients with BCC, SCC, actinic keratosis (AK), and psoriasis.